SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
DOR BioPharma, (DORB)
An SI Board Since April 2007
Posts SubjectMarks Bans Symbol
35 2 0 DORB
Emcee:  Paul Lee Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
35Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD PrevePaul Lee-5/12/2010
34Soligenix Announces Initiation of its Confirmatory Phase 3 Clinical Trial of orBPaul Lee-10/15/2009
33The long term indicators continue to look terrific, shares are based in the low Benny-Rubin-10/3/2009
32DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the TreatmenPaul Lee-8/4/2009
31Benny Volume prelude to big moves ! EMEA gives Dorb green liteSupervalue-6/10/2009
30VOLUME alarm and running !Supervalue-6/9/2009
29Volume alarm went off ........ a good signSupervalue-2/12/2009
28Huge news today! Were going places :)_Benny-Rubin-2/12/2009
27High of 18 cents today !Supervalue-1/9/2009
26DORB very nice and greenSupervalue-1/8/2009
25This Company is 2 towns over from where I live. It's just starting to catch Benny-Rubin-1/6/2009
24DORB Good pick for 2009 , Benny thinks to the moon take your word as good as golSupervalue-1/6/2009
23DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of AcuPaul Lee-1/6/2009
22DORB is a Sleeping Giant down here IMHO. Going long big time on thisBenny-Rubin-1/5/2009
21DOR BioPharma Receives SPA Clearance From the FDA to Begin Confirmatory Phase 3 Paul Lee-1/5/2009
20DOR BioPharma Announces FDA Clearance of IND for DOR201 in Radiation Enteritis MPaul Lee-12/8/2008
19DORB .09 +20%. They are bidding their time waiting on the FDA to be cooperative.Findit-11/25/2008
18DOR BioPharma's orBec(R) Receives Orphan Drug Designation in Australia for tPaul Lee-11/25/2008
17DOR BioPharma Announces Second orBec(R) Clinical Summary Published in "ExpePaul Lee-9/15/2008
16DOR BioPharma Announces Initiation of Second Human Clinical Trial for RiVax(TM),Paul Lee-8/7/2008
15DOR BioPharma Announces Named Patient Access Program for orBec(R) in Singapore aPaul Lee-7/18/2008
14DOR BioPharma Enters Into Collaborative Agreement With IDIS for Named Patient AcPaul Lee-7/15/2008
13DOR BioPharma Announces Positive New Pulmonary Effect Data From orBec(R) ClinicaPaul Lee-2/13/2008
12DOR BioPharma Reports Achievement of Two-Year Stability Milestone for RiVax(TM),Paul Lee-1/29/2008
11DOR BioPharma Receives Orphan Drug Designation for Oral BDP for the Treatment ofPaul Lee-1/3/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News